speb/financial-data huggingface dataset:
COUR.PA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1633000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 72357.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: -1000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 47000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Inventories: -1000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Properties: 385000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Other Receivables: 250000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Payables: 486000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 192000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -442000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Share Issued: 72780.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 18219000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 18219000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 215000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Assets: 27692000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 22260000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Debt: 4614000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 18194000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9498000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 12439000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 5821000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 277000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 423.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 43000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Work In Process: 114000.00
COUR.PA balance_sheet (quarterly, 2025-06-30) — Working Capital: 11576000.00
COUR.PA income_statement (annual, 2025-12-31) — +Operating Expense: 2081000.00
COUR.PA income_statement (annual, 2025-12-31) — +Total Revenue: 2563000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Accounts Payable: 305000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 305000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2085000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2085000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -212000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -212000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
COUR.PA income_statement (annual, 2025-12-31) — Basic Average Shares: 72264.00
COUR.PA income_statement (annual, 2025-12-31) — Basic EPS: -5.30
COUR.PA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6425000.00
COUR.PA cash_flow (annual, 2025-12-31) — Capital Expenditure: -4343000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 162000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 162000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Capital Stock: 1674000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1674000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4247000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4247000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4247000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4247000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Cash Financial: 4247000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 4247000.00
COUR.PA cash_flow (annual, 2025-12-31) — Change In Working Capital: 1127000.00
COUR.PA cash_flow (annual, 2025-12-31) — Changes In Cash: -2179000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Common Stock: 1674000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Common Stock: 1674000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 18285000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 18285000.00
COUR.PA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
COUR.PA cash_flow (annual, 2025-12-31) — Common Stock Payments: -104000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
COUR.PA income_statement (annual, 2025-12-31) — Cost Of Revenue: 1985000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Assets: 12727000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Assets: 12727000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 33000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 33000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Debt: 1570000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Debt: 1570000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1603000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1603000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 36000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 36000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Liabilities: 4144000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4144000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Current Provisions: 291000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Current Provisions: 291000.00
COUR.PA cash_flow (annual, 2025-12-31) — Deferred Tax: -110000.00
COUR.PA cash_flow (annual, 2025-12-31) — Depreciation: 40000.00
COUR.PA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 40000.00
COUR.PA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 135000.00
COUR.PA income_statement (annual, 2025-12-31) — Depreciation Income Statement: 135000.00
COUR.PA income_statement (annual, 2025-12-31) — Diluted Average Shares: 72264.00
COUR.PA income_statement (annual, 2025-12-31) — Diluted EPS: -5.30
COUR.PA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -383000.00
COUR.PA cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
COUR.PA income_statement (annual, 2025-12-31) — EBIT: -298000.00
COUR.PA income_statement (annual, 2025-12-31) — EBITDA: -163000.00
COUR.PA cash_flow (annual, 2025-12-31) — End Cash Position: 4247000.00
COUR.PA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1001000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Finished Goods: 5996000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Finished Goods: 5996000.00
COUR.PA cash_flow (annual, 2025-12-31) — Free Cash Flow: -4096000.00
COUR.PA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -633000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
COUR.PA balance_sheet (annual, 2025-12-31) — Gross PPE: 385000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 385000.00
COUR.PA income_statement (annual, 2025-12-31) — Gross Profit: 578000.00
COUR.PA income_statement (annual, 2025-12-31) — Interest Expense: 150000.00
COUR.PA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 150000.00
COUR.PA income_statement (annual, 2025-12-31) — Interest Income: 11000.00
COUR.PA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 11000.00
COUR.PA cash_flow (annual, 2025-12-31) — Interest Paid Cff: -139000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -190000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -190000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Inventory: 5920000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Inventory: 5920000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Invested Capital: 23586000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 23586000.00
COUR.PA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -3427000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Investment Properties: 14174000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Investment Properties: 14174000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 849000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 849000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 0.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 0.00
COUR.PA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
COUR.PA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3390000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 129000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 129000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Long Term Debt: 3731000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3731000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3860000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3860000.00
COUR.PA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3390000.00
COUR.PA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2146000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 0.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 0.00
COUR.PA balance_sheet (annual, 2025-12-31) — Minority Interest: 15000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 15000.00
COUR.PA income_statement (annual, 2025-12-31) — Minority Interests: -46000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -104000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Net Debt: 1054000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Net Debt: 1054000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income: -383000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -383000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -337000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -383000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -383000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -337000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -337000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Interest Income: -139000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -16000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1244000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1244000.00
COUR.PA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -139000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Net PPE: 173000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Net PPE: 173000.00
COUR.PA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3411000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 18285000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 18285000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 21000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 21000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1639000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1639000.00
COUR.PA income_statement (annual, 2025-12-31) — Normalized EBITDA: -163000.00
COUR.PA income_statement (annual, 2025-12-31) — Normalized Income: -383000.00
COUR.PA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 247000.00
COUR.PA income_statement (annual, 2025-12-31) — Operating Income: -1503000.00
COUR.PA income_statement (annual, 2025-12-31) — Operating Revenue: 2563000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 72357.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 72357.00
COUR.PA cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Other Current Assets: 1000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 60000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 60000.00
COUR.PA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 139000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1000.00
COUR.PA income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 76000.00
COUR.PA income_statement (annual, 2025-12-31) — Other Operating Expenses: 1915000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Other Properties: 385000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Other Properties: 385000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Other Receivables: 101000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 101000.00
COUR.PA income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
COUR.PA balance_sheet (annual, 2025-12-31) — Payables: 571000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Payables: 571000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 11000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 11000.00
COUR.PA income_statement (annual, 2025-12-31) — Pretax Income: -448000.00
COUR.PA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -16000.00
COUR.PA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4343000.00
COUR.PA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1985000.00
COUR.PA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 40000.00
COUR.PA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2146000.00
COUR.PA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -104000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Retained Earnings: -383000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -383000.00
COUR.PA cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
COUR.PA cash_flow (annual, 2025-12-31) — Sale Of PPE: 932000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Share Issued: 72780.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Share Issued: 72780.00
COUR.PA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 18285000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 18285000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 18285000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 18285000.00
COUR.PA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
COUR.PA income_statement (annual, 2025-12-31) — Tax Provision: -110000.00
COUR.PA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
COUR.PA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 326000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 326000.00
COUR.PA cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 0.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Assets: 27944000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Assets: 27944000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Capitalization: 22016000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 22016000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Debt: 5463000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Debt: 5463000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 18300000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 18300000.00
COUR.PA income_statement (annual, 2025-12-31) — Total Expenses: 4066000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 9644000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 9644000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 15217000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 15217000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5500000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5500000.00
COUR.PA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -286000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 266000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 266000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 423.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 423.00
COUR.PA balance_sheet (annual, 2025-12-31) — Work In Process: 114000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Work In Process: 114000.00
COUR.PA balance_sheet (annual, 2025-12-31) — Working Capital: 8583000.00
COUR.PA balance_sheet (quarterly, 2025-12-31) — Working Capital: 8583000.00
COV.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1728804.00
COV.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 417368.00
COV.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 31919.00
COV.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -2154.00
COV.AX income_statement (annual, 2023-06-30) — Amortization: 2154.00
COV.AX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 2154.00
COV.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 26260276.00
COV.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.07
COV.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 42751.00
COV.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -340239.00
COV.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 46531.00
COV.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 239774.00
COV.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 239774.00
COV.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 239774.00
COV.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 1221727.00
COV.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -340239.00
COV.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -684465.00
COV.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 197023.00
COV.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -684465.00
COV.AX balance_sheet (annual, 2023-06-30) — Common Stock: 46531.00
COV.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: -943415.00
COV.AX balance_sheet (annual, 2023-06-30) — Current Assets: 580212.00
COV.AX balance_sheet (annual, 2023-06-30) — Current Debt: 1600000.00
COV.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 1600000.00
COV.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 2020044.00
COV.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 43821.00
COV.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 43821.00
COV.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 41667.00
COV.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 26260276.00
COV.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.07
COV.AX income_statement (annual, 2023-06-30) — EBIT: -1618724.00
COV.AX income_statement (annual, 2023-06-30) — EBITDA: -1574903.00
COV.AX cash_flow (annual, 2023-06-30) — End Cash Position: 239774.00
COV.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1221727.00
COV.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -1024704.00
COV.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 783485.00
COV.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1097275.00
COV.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 458333.00
COV.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 40238.00
COV.AX income_statement (annual, 2023-06-30) — Interest Expense: 110776.00
COV.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 110776.00
COV.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 656585.00
COV.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -340239.00
COV.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 1603250.00
COV.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 1603250.00
COV.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -200000.00
COV.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 40238.00
COV.AX balance_sheet (annual, 2023-06-30) — Net Debt: 1360226.00
COV.AX income_statement (annual, 2023-06-30) — Net Income: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1729500.00
COV.AX cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -300000.00
COV.AX income_statement (annual, 2023-06-30) — Net Interest Income: -110776.00
COV.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 1403250.00
COV.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 1403250.00
COV.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -110776.00
COV.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -181523.00
COV.AX balance_sheet (annual, 2023-06-30) — Net PPE: 38084.00
COV.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -40239.00
COV.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: -1401748.00
COV.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1574903.00
COV.AX income_statement (annual, 2023-06-30) — Normalized Income: -1729500.00
COV.AX income_statement (annual, 2023-06-30) — Operating Income: -1728804.00
COV.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 45000001.00
COV.AX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 1600000.00
COV.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 783485.00
COV.AX income_statement (annual, 2023-06-30) — Other Income Expense: 110080.00
COV.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 458333.00
COV.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 110080.00
COV.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 587708.00
COV.AX balance_sheet (annual, 2023-06-30) — Payables: 417368.00
COV.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 417368.00
COV.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -684465.00
COV.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2676.00
COV.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 308519.00
COV.AX income_statement (annual, 2023-06-30) — Pretax Income: -1729500.00
COV.AX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -300000.00
COV.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -40239.00
COV.AX balance_sheet (annual, 2023-06-30) — Receivables: 31919.00
COV.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 43821.00
COV.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -200000.00
COV.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -1773431.00
COV.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 1097275.00
COV.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1097275.00
COV.AX balance_sheet (annual, 2023-06-30) — Share Issued: 45000001.00
COV.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: -943415.00
COV.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: -1401748.00
COV.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
COV.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
COV.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Assets: 1076629.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: -943415.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Debt: 1600000.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: -943415.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 2020044.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 496417.00
COV.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
COV.AX balance_sheet (annual, 2023-06-30) — Working Capital: -1439832.00
COV.AX income_statement (annual, 2024-06-30) — +Operating Expense: 4332865.00
COV.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 439863.00
COV.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 57444.00
COV.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -11339.00
COV.AX income_statement (annual, 2024-06-30) — Amortization: 50000.00
COV.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 50000.00
COV.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 117321039.00
COV.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.03
COV.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 239774.00
COV.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -3047.00
COV.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 13706586.00
COV.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 9372763.00
COV.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 9372763.00
COV.AX balance_sheet (annual, 2024-06-30) — Cash Equivalents: 2049673.00
COV.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 7323090.00
COV.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 11166213.00
COV.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -3047.00
COV.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2030177.00
COV.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 9132989.00
COV.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -2589808.00
COV.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 210812.00
COV.AX balance_sheet (annual, 2024-06-30) — Common Stock: 13706586.00
COV.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 10610143.00
COV.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 12000000.00
COV.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -833787.00
COV.AX balance_sheet (annual, 2024-06-30) — Current Assets: 9437969.00
COV.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 486216.00
COV.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 59185.00
COV.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 59185.00
COV.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 9185.00
COV.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 117321039.00
COV.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.03
COV.AX income_statement (annual, 2024-06-30) — EBIT: -3732718.00
COV.AX income_statement (annual, 2024-06-30) — EBITDA: -3673533.00
COV.AX cash_flow (annual, 2024-06-30) — End Cash Position: 9372763.00
COV.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 11166213.00
COV.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -2033224.00
COV.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 2436222.00
COV.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 901713.00
COV.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 816666.00
COV.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 43285.00
COV.AX income_statement (annual, 2024-06-30) — Interest Expense: 26516.00
COV.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 26516.00
COV.AX income_statement (annual, 2024-06-30) — Interest Income: 362819.00
COV.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 362819.00
COV.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 348819.00
COV.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 10610143.00
COV.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -3047.00
COV.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 12000000.00
COV.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 43285.00
COV.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 11166213.00
COV.AX income_statement (annual, 2024-06-30) — Net Income: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Net Interest Income: 336303.00
COV.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 336303.00
COV.AX balance_sheet (annual, 2024-06-30) — Net PPE: 31946.00
COV.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -3047.00
COV.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 9793477.00
COV.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -3673533.00
COV.AX income_statement (annual, 2024-06-30) — Normalized Income: -3759234.00
COV.AX income_statement (annual, 2024-06-30) — Operating Income: -4332865.00
COV.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 128500001.00
COV.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 2436222.00
COV.AX income_statement (annual, 2024-06-30) — Other Income Expense: 237328.00
COV.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 816666.00
COV.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 237328.00
COV.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 3137726.00
COV.AX balance_sheet (annual, 2024-06-30) — Payables: 439863.00
COV.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 439863.00
COV.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -2589808.00
COV.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 46353.00
COV.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 7762.00
COV.AX income_statement (annual, 2024-06-30) — Pretax Income: -3759234.00
COV.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -3047.00
COV.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Government Grants: 210812.00
COV.AX balance_sheet (annual, 2024-06-30) — Receivables: 57444.00
COV.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 59185.00
COV.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -833787.00
COV.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -5532665.00
COV.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 901713.00
COV.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 234241.00
COV.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1135954.00
COV.AX balance_sheet (annual, 2024-06-30) — Share Issued: 128500001.00
COV.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 10610143.00
COV.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 9793477.00
COV.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
COV.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
COV.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Assets: 10286581.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 10610143.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 10610143.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 486216.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 848612.00
COV.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
COV.AX balance_sheet (annual, 2024-06-30) — Working Capital: 8951753.00
COV.AX income_statement (annual, 2025-06-30) — +Operating Expense: 5183896.00
COV.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 870774.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 870774.00
COV.AX balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -21813.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -21813.00
COV.AX income_statement (annual, 2025-06-30) — Amortization: 50000.00
COV.AX income_statement (annual, 2025-06-30) — Amortization Of Intangibles Income Statement: 50000.00
COV.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 128500001.00
COV.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.03
COV.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 9372763.00
COV.AX cash_flow (annual, 2025-06-30) — Capital Expenditure: -11122.00
COV.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 13706586.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 13706586.00
COV.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 6460511.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6460511.00
COV.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6460511.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6460511.00
COV.AX balance_sheet (annual, 2025-06-30) — Cash Equivalents: 5713495.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 5713495.00
COV.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 747016.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 747016.00
COV.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
COV.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -11122.00
COV.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2901130.00
COV.AX cash_flow (annual, 2025-06-30) — Changes In Cash: -2912252.00
COV.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -4055022.00
COV.AX cash_flow (annual, 2025-06-30) — Classesof Cash Receiptsfrom Operating Activities: 845172.00
COV.AX balance_sheet (annual, 2025-06-30) — Common Stock: 13706586.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 13706586.00
COV.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 5834443.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5834443.00
COV.AX balance_sheet (annual, 2025-06-30) — Current Assets: 6545254.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 6545254.00
COV.AX balance_sheet (annual, 2025-06-30) — Current Liabilities: 1101738.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1101738.00
COV.AX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 60474.00
COV.AX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 60474.00
COV.AX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 10474.00
COV.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 128500001.00
COV.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.03
COV.AX income_statement (annual, 2025-06-30) — EBIT: -5183896.00
COV.AX income_statement (annual, 2025-06-30) — EBITDA: -5123422.00
COV.AX cash_flow (annual, 2025-06-30) — End Cash Position: 6460511.00
COV.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: 0.00
COV.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: -2912252.00
COV.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1659656.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1659656.00
COV.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 1726555.00
COV.AX balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 358333.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 358333.00
COV.AX balance_sheet (annual, 2025-06-30) — Gross PPE: 54407.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 54407.00
COV.AX income_statement (annual, 2025-06-30) — Interest Income: 339590.00
COV.AX income_statement (annual, 2025-06-30) — Interest Income Non Operating: 339590.00
COV.AX cash_flow (annual, 2025-06-30) — Interest Received Direct: 308720.00
COV.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 5834443.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5834443.00
COV.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: -11122.00
COV.AX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 54407.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 54407.00
COV.AX income_statement (annual, 2025-06-30) — Net Income: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Net Interest Income: 339590.00
COV.AX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 339590.00
COV.AX balance_sheet (annual, 2025-06-30) — Net PPE: 32594.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 32594.00
COV.AX cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -11122.00
COV.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 5476110.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5476110.00
COV.AX income_statement (annual, 2025-06-30) — Normalized EBITDA: -5123422.00
COV.AX income_statement (annual, 2025-06-30) — Normalized Income: -3999134.00
COV.AX income_statement (annual, 2025-06-30) — Operating Income: -5183896.00
COV.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 128500001.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 128500001.00
COV.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 1659656.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1659656.00
COV.AX income_statement (annual, 2025-06-30) — Other Income Expense: 845172.00
COV.AX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 358333.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 358333.00
COV.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: 845172.00
COV.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 3282884.00
COV.AX balance_sheet (annual, 2025-06-30) — Other Payable: 129154.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 129154.00
COV.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 70570.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 70570.00
COV.AX balance_sheet (annual, 2025-06-30) — Payables: 999928.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Payables: 999928.00
COV.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 999928.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 999928.00
COV.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -4055022.00
COV.AX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 101810.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 101810.00
COV.AX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 14173.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 14173.00
COV.AX income_statement (annual, 2025-06-30) — Pretax Income: -3999134.00
COV.AX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -11122.00
COV.AX cash_flow (annual, 2025-06-30) — Receiptsfrom Government Grants: 845172.00
COV.AX balance_sheet (annual, 2025-06-30) — Receivables: 70570.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 70570.00
COV.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 60474.00
COV.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: -9531799.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -9531799.00
COV.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 1726555.00
COV.AX income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 113983.00
COV.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 1840538.00
COV.AX balance_sheet (annual, 2025-06-30) — Share Issued: 128500001.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 128500001.00
COV.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 5834443.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 5834443.00
COV.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 5476110.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 5476110.00
COV.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
COV.AX income_statement (annual, 2025-06-30) — Tax Provision: 0.00
COV.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Assets: 6936181.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 6936181.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 5834443.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 5834443.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 5834443.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 5834443.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 1101738.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1101738.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 390927.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 390927.00
COV.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
COV.AX balance_sheet (annual, 2025-06-30) — Working Capital: 5443516.00
COV.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 5443516.00
COV.PA cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -339570000.00
COV.PA balance_sheet (annual, 2021-12-31) — Construction In Progress: 23076000.00
COV.PA balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 53337000.00
COV.PA cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
COV.PA balance_sheet (annual, 2021-12-31) — Other Current Assets: 1000.00
COV.PA income_statement (annual, 2022-12-31) — +Operating Expense: 72790000.00
COV.PA income_statement (annual, 2022-12-31) — +Total Revenue: 905981000.00
COV.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 146847000.00
COV.PA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 254036000.00
COV.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -584328000.00
COV.PA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4053017000.00
COV.PA balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -37253000.00
COV.PA balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 259400000.00
COV.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 15798000.00
COV.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 93902269.00
COV.PA income_statement (annual, 2022-12-31) — Basic EPS: 6.61
COV.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1060791000.00
COV.PA balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1900374000.00
COV.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -567834000.00
COV.PA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 307088000.00
COV.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 284358000.00
COV.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 461541000.00
COV.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 461541000.00
COV.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -353335000.00
COV.PA balance_sheet (annual, 2022-12-31) — Cash Equivalents: 19430000.00
COV.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 442111000.00
COV.PA cash_flow (annual, 2022-12-31) — Change In Inventory: -3346000.00
COV.PA cash_flow (annual, 2022-12-31) — Change In Payable: -128780000.00
COV.PA cash_flow (annual, 2022-12-31) — Change In Receivables: 49184000.00
COV.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -82942000.00
COV.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -634506000.00
COV.PA balance_sheet (annual, 2022-12-31) — Common Stock: 284358000.00
COV.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -353335000.00
COV.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 9443010000.00
COV.PA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
COV.PA cash_flow (annual, 2022-12-31) — Common Stock Payments: -38449000.00
COV.PA balance_sheet (annual, 2022-12-31) — Construction In Progress: 68470000.00
COV.PA income_statement (annual, 2022-12-31) — Cost Of Revenue: 69257000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Assets: 1713316000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 8882000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Debt: 1232805000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1241687000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Liabilities: 1921151000.00
COV.PA balance_sheet (annual, 2022-12-31) — Current Provisions: 17767000.00
COV.PA cash_flow (annual, 2022-12-31) — Deferred Tax: 137929000.00
COV.PA cash_flow (annual, 2022-12-31) — Depreciation: 62272000.00
COV.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 62272000.00